Literature DB >> 2557082

Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoproterenol.

C Ventura1, L Bastagli, P Bernardi, C M Caldarera, C Guarnieri.   

Abstract

The present study demonstrates the presence of opioid receptors in the rat cardiac sarcolemma isolated by the hypotonic LiBr-shock procedure. Opioid binding was measured by using [3H]U69 593, [3H](2-D-penicillamine,5-D-penicillamine)enkephalin ([3H]DPDPE) or [3H][D-Ala2,MePhe4,Gly-(ol)5]enkephalin ([3H]DAGO) as selective radioligands for K, delta and mu opioid receptors, respectively. Both the K- and delta-selective ligands exhibited highly specific (75-86%) binding, saturable at a concentration of about 20 nM. No specific binding for the selective agonist DAGO was observed. A marked increase in both [3H]U69 593 and [3H]DPDPE binding was observed after incubation of the sarcolemma with the alpha-adrenoceptor agonist phenylephrine or with the beta-adrenoceptor agonist isoproterenol. These stimulatory effects were associated with an increase in the Bmax values, a decrease in the Kd values, and were completely antagonized by the respective antagonists phentolamine and propranolol.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2557082     DOI: 10.1016/0005-2736(89)90456-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

1.  Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma.

Authors:  F Niroomand; R A Mura; L Piacentini; W Kübler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

2.  Neurochemically distinct circuitry regulates locus coeruleus activity during female social stress depending on coping style.

Authors:  Beverly A S Reyes; Xiao-Yan Zhang; Elsa C Dufourt; Seema Bhatnagar; Rita J Valentino; Elisabeth J Van Bockstaele
Journal:  Brain Struct Funct       Date:  2019-02-14       Impact factor: 3.270

Review 3.  Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse.

Authors:  Ivone Gomes; Wakako Fujita; Moraje V Chandrakala; Lakshmi A Devi
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

Review 4.  Opioid-induced cardioprotection.

Authors:  Katsuya Tanaka; Judy R Kersten; Matthias L Riess
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 5.  Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10.

Authors:  Wakako Fujita; Ivone Gomes; Lakshmi A Devi
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

6.  Effect of U50,488H, a κ-opioid receptor agonist on myocardial α-and β-myosin heavy chain expression and oxidative stress associated with isoproterenol-induced cardiac hypertrophy in rat.

Authors:  Amardeep Jaiswal; Santosh Kumar; Sandeep Seth; Amit Kumar Dinda; Subir Kumar Maulik
Journal:  Mol Cell Biochem       Date:  2010-08-21       Impact factor: 3.396

7.  Lack of effect of kappa-opioid receptor agonism on long-term methamphetamine-induced neurotoxicity in rats.

Authors:  Kamisha L Johnson-Davis; Glen R Hanson; Kristen A Keefe
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

8.  Hypertensive state, independent of hypertrophy, exhibits an attenuated decrease in systolic function on cardiac kappa-opioid receptor stimulation.

Authors:  Craig Bolte; Gilbert Newman; Jo El J Schultz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

9.  Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits.

Authors:  T Miki; M V Cohen; J M Downey
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

10.  Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusion.

Authors:  Eric R Gross; Anna K Hsu; Garrett J Gross
Journal:  Anesth Analg       Date:  2009-11       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.